Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yikuan Wu, Zhengnan Ren, Shenglong Zhu, Yunzhou Wu, Gang Wang, Hao Zhang, Wei Chen, Zhao He, Xian-long Ye, Qixiao Zhai
Topics & Concepts
FGF21SulforaphaneInternal medicineFatty liverEndocrinologyLipogenesisLipolysisSteatosisSteatohepatitisFibroblast growth factorAdipose tissueMedicineCancer researchDiseaseReceptorFibroblast Growth Factor ResearchKruppel-like factors researchEpigenetics and DNA Methylation